Skip to main content
Retour
NTRA logo

Natera, Inc.

Qualité des données : 100%
NTRA
NASDAQ Healthcare Medical - Diagnostics & Research
197,37 €
▲ 2,85 € (1,47%)
Cap. Boursière : 27,97B
Fourchette du Jour
195,79 € 202,88 €
Fourchette 52 Semaines
125,38 € 256,36 €
Volume
655 434
Moyenne 50J / 200J
216,00 € / 191,28 €
Clôture Précédente
194,52 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (627 pairs)

Métrique Action Médiane du Secteur
P/E -134,4 0,3
P/B 16,3 3,0
ROE % -14,3 3,7
Net Margin % -9,0 3,8
Rev Growth 5Y % 38,6 10,0
D/E 0,1 0,2

Objectif de Cours des Analystes

Hold
249,57 € +26.4%
Low: 172,00 € High: 285,00 €
BPA Prévisionnel
-1,81 €
CA Est.
2,67B

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 4,28 €
4,18 € – 4,44 €
5,01B 5
FY2029 1,78 €
1,73 € – 1,84 €
4,36B 11
FY2028 1,04 €
-1,15 € – 3,73 €
3,82B 13

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 -0,51 € 0,35 € +168,4%
2025-11-06 -0,39 € -0,64 € -65,9%
2025-08-07 -0,62 € -0,74 € -20,2%
2025-05-08 -0,64 € -0,50 € +21,9%
2025-02-27 -0,38 € -0,41 € -7,6%
2024-11-12 -0,57 € -0,26 € +54,4%
2024-08-08 -0,69 € -0,30 € +56,5%
2024-05-09 -0,71 € -0,56 € +21,1%

Dividend History

Yield

0,00%

Payout Ratio

0,00%

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Points Clés

Revenue grew 38,57% annually over 5 years — strong growth
Debt/Equity of 0,13 — conservative balance sheet
Generating 109,11M in free cash flow
Capital efficient — spends only 4,60% of revenue on capex

Croissance

Revenue Growth (5Y)
38,57%
Revenue (1Y)35,90%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-14,32%
ROIC-12,06%
Net Margin-9,03%
Op. Margin-13,44%

Sécurité

Debt / Equity
0,13
Current Ratio3,39
Interest Coverage-76,16

Valorisation

P/E Ratio
-134,38
Forward P/EN/A
P/B Ratio16,34
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 35,90% Revenue Growth (3Y) 45,95%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 38,57% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,31B Net Income (TTM) -208,16M
ROE -14,32% ROA -8,30%
Gross Margin 64,85% Operating Margin -13,44%
Net Margin -9,03% Free Cash Flow (TTM) 109,11M
ROIC -12,06% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,13 Current Ratio 3,39
Interest Coverage -76,16
Dividends
Dividend Yield 0,00% Payout Ratio 0,00%
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -134,38 Forward P/E N/A
P/B Ratio 16,34 P/S Ratio 12,13
PEG Ratio 230,22 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S 10,48 Fwd Earnings Yield N/A
FCF Yield 0,39%
Market Cap 27,97B Enterprise Value 27,11B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 2,31B 1,70B 1,08B 820,22M 625,49M
Net Income -208,16M -190,43M -434,80M -547,80M -471,72M
EPS (Diluted) -1,52 -1,53 -3,78 -5,57 -5,21
Gross Profit 1,50B 1,02B 492,74M 363,97M 307,07M
Operating Income -309,91M -222,29M -446,25M -541,04M -468,17M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,51B 1,66B 1,44B 1,39B 1,24B
Total Liabilities 795,62M 465,32M 676,37M 688,73M 583,18M
Shareholders' Equity 1,71B 1,20B 765,33M 705,74M 653,30M
Total Debt 214,38M 187,12M 441,99M 446,22M 397,23M
Cash & Equivalents 1,08B 945,59M 642,10M 466,09M 84,39M
Current Assets 1,50B 1,38B 1,26B 1,21B 1,09B
Current Liabilities 441,23M 344,05M 307,27M 310,50M 218,96M